Development of 3D organ-specific models of colorectal cancer metastasis

描述(由申请人提供)：了解癌症转移的生物学对于改善癌症治疗至关重要。这些努力中的一个关键挑战是缺乏简单易用的肿瘤模型来概括转移疾病的状况或过程。目前的模型要么太难研究，要么无法复制肿瘤转移的复杂微环境。我们的应用旨在通过应用组织工程学的最新进展来解决对癌症转移模型的需求。组织工程学的最新突破是脱细胞组织的发展。里德博士开发的一种生成脱细胞组织的新技术，除了细胞外基质外，还保留了与基质结合的生长因子和细胞因子。使用这种技术产生的脱细胞组织被称为生物基质支架。Reid小组已经证明，生物基质支架在化学和功能上都是组织特定的，但不是物种特定的。使用生物基质支架，我们已经获得了令人兴奋的初步数据。我们发现，结直肠癌细胞HT29、SW480和CaCO2可以自发地在涂有肝和肺生物基质支架的组织培养皿上形成3D克隆。更重要的是，我们已经证明了生长在肝和肺生物基质支架上的细胞对化疗和放疗的治疗反应是不同的。这种器官特异性反应在其他3D培养系统中没有观察到。最后，我们发现来自结直肠癌肝转移的原代肿瘤细胞在体外培养在肝生物基质上的集落数明显多于在肺生物基质、胶原或塑料上生长的集落。根据我们的初步数据，我们假设我们可以使用BioMatrix支架来建立癌症转移的3D体外和体外模型。在这一应用中，我们计划将结直肠癌作为模型疾病，并建立结直肠癌肝和肺转移的模型。我们的理论认为，我们提出的模型可以概括结直肠癌转移到肝和肺的生物学特性，以及预测转移的治疗反应。我们的应用程序有两个具体目标。第一个目标将集中在仅使用组织特异性生物基质支架的结直肠癌转移的体外器官特异性3D模型的开发上。我们的第二个目标将集中在利用肝脏生物基质支架再细胞化制备的肝脏器官类化合物建立结直肠癌肝转移的3D体外模型。我们的研究取得成功，可以开发出能够更好地模拟疾病过程的新的体外/体外癌症转移模型。这些可能成为研究转移生物学的有力工具，包括：转移机制；物理力量在转移中的作用；以及识别控制转移潜能的基质成分。此外，模型可用于针对癌症转移到特定器官的体外治疗性筛选试验。我们的策略也可以应用于其他类型的癌症和转移到其他器官。

DESCRIPTION (provided by applicant): Understanding the biology of cancer metastases is critical to improving the treatment of cancer. A key challenge in these efforts has been the lack of easy-to-use tumor models that can recapitulate the metastatic disease condition or process. Current models are either too difficult to study or unable to replicate the complex microenvironment of tumor metastasis. Our application aims to address the need for models of cancer metastasis by applying recent advances in tissue engineering. A recent breakthrough in tissue engineering has been the development of decellularized tissue. One novel technique for generating decellularized tissue, developed by Dr. Reid, preserves growth factors and cytokines that are matrix-bound in addition to the extracellular matrix. Decellularized tissue generated using this technique has been termed biomatrix scaffolds. The Reid group has shown that biomatrix scaffolds are tissue-specific but not species-specific both chemically and functionally. Using biomatrix scaffolds, we have obtained exciting preliminary data. We have found that colorectal cancer cells, HT29, SW480 and CaCO2, can spontaneously form 3D colonies on tissue culture dishes coated with liver and lung biomatrix scaffolds. More importantly, we have demonstrated that treatment responses to chemotherapy and radiotherapy are different between cells grown on liver and lung biomatrix scaffolds. Such organ-specific responses have not been observed with other 3D culture systems. Lastly, we have shown that human primary tumor cells from hepatic metastases of colorectal cancer form significantly more colonies when grown on liver biomatrix in vitro compared to that on lung biomatrix, collagen or plastic. Based on our preliminary data, we hypothesize that we can use biomatrix scaffolds to generate 3D in vitro and ex vivo models of cancer metastasis. In this application, we plan to use colorectal cancer as a model disease and develop models of colorectal cancer with liver and lung metastases. We theorize that our proposed models can recapitulate the biology of colorectal cancer metastasis to liver and lung as well as predict treatment responses of metastases. Our application has two specific aims. The first aim will focus on the development of in vitro organ-specific 3D models of colorectal cancer metastasis using tissue-specific biomatrix scaffolds only. Our second aim will focus on the development of 3D ex vivo models of colorectal cancer liver metastases using liver organoids prepared by recellularization of liver biomatrix scaffolds. Success with our research can lead to the development of novel in vitro/ex vivo models of cancer metastasis that can better mimic the disease process. These can become powerful tools for studying the biology of metastasis including: mechanisms of metastasis; roles of physical forces on metastasis; and identification of matrix components controlling metastatic potential. Furthermore, models can be useful for in vitro therapeutic screening assays targeted towards cancer metastasis to a specific organ. Our strategy can also be applied to other types of cancers and metastasis to other organs.